Feb 24 (Reuters) - Regis Healthcare Ltd (REG)
- Anticipates H2 ebitda to be in line with H1 result
- Total capex spend in FY17 is anticipated to be in order of $160 MLN
- FY17 net rad inflows are anticipated to be circa $100 MLN following first half result of $46.6 MLN
- FY17 depreciation expense range is anticipated to be $28 MLN - $31 MLN, following a H1 expense of $14.2MLN
- Interest expense for FY17 is anticipated to be circa $8 MLN for full year
- Debt will remain at approximately 2X ebitda in FY2017
Feb 24 (Reuters) - Regis Healthcare Ltd (REG) Anticipates H2...
Add REG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.48 |
Change
-0.220(3.28%) |
Mkt cap ! $1.755B | |||
| Open | High | Low | Value | Volume |
| $6.75 | $6.87 | $6.48 | $36.64M | 5.637M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $6.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.48 | 8854 | 1 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| REG (ASX) Chart |
